Clinical Trials Browser

Myelodysplastic Syndromes × Bortezomib × 90 days × Clear all

NCT02211755 2026-04-28

Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

Phase 1 Completed

LymphoidMyeloid

Lymphoma, Myelodysplastic Syndromes, Neoplasms